Submit Your Clinical Trial!
The Heart Rhythm Society recognizes that exciting and rapidly evolving research was not concluded in time for the December 9, 2019 abstract submission deadline. To highlight timely and novel work at #HRS2020, the Scientific Sessions Program Committee developed a peer-reviewed session of late-breaking clinical trials (LBCT) that allows for later submission.
The Late-Breaking Clinical Trials Submission Site is now open. The submission deadline is Friday, March 6, 2020, 11:59 PM EST
Each abstract submission will require a fee of $175 for HRS members and $250 for nonmembers. Become an HRS member today to submit for free. Nonrefundable submission fees will be used to fund travel grants for fellows-in-training. The Heart Rhythm Society (HRS) encourages and supports the efforts of early career electrophysiologists and other heart rhythm professionals to participate in the Society’s activities.
To that end, the Heart Rhythm Travel Scholarships support participation in the Annual Scientific Sessions with a complimentary registration to Heart Rhythm and up to $1,500 in reimbursement of travel costs.
The scholarship application deadline is Tuesday, February 11, 2020.
Payments must be made by credit card during the submission process. Visa, MasterCard, and American Express are accepted.
Submitters are encouraged to use the Late-Breaking Clinical Trials Submission Guidelines as a tool for success. This resource includes everything you need to know about submitting a clinical trial for presentation at the Annual Scientific Sessions.
- Important Information
- Submitting Author Designation
- Rules for Submission Eligibility
- Investigator Requirements
- LBCT Abstract Categories
- Acceptance & Registration Information
Discounts for HRS Members
Not a member?
Join today to qualify for discounts on abstract submission and registration rates. Membership applications can take up to four business days to be reviewed: if you apply then please wait to submit your abstract until you are told that your membership is approved. Learn more.
Abstract Submission Guideline Requirements
Author Designation Information: With the SSO login, the Submitting Author is the Presenting Author and listed as the First Author for all abstracts. The contact information of the submitter of the abstract will automatically populate the submission information for the Presenting Author and First Author fields. All correspondence and registration information for the abstract will be directed to the Submitting Author only. The Submitting Author is responsible for making sure that their contact information is current during the submission process.
Authors should carefully consider the designation of the Submitting/Presenting/First Author before initiating the abstract submission process. Each Submitting Author will be required to login using their HRS account login. If you do not have a username/password or have forgotten the information, or if you are unable to reset your password and need further assistance, contact Membership at (202) 464-9855. The Submitting Author's information will pre-populate as the Presenting Author and First Author information fields upon signing into the submission site.
Registration: The Presenting Author (Submitting Author) is required to register for Scientific Sessions at the reduced registration fee. Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter. Only one author per abstract is considered the presenter. Co-Author(s) listed on the abstract do not receive reduced rates towards registration. For more information, please review the Presenter Registration Information page.
Regular Abstract Submission: Accepted abstracts are embargoed until 5:00 PM PDT on Tuesday, May 5, 2020. This means that information regarding any abstract submission may not be released before this time. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation.
Late-Breaking Clinical Trials Submission: Accepted Late-Breaking Clinical Trials abstracts are embargoed until the time of presentation. This means that the Society will release these abstracts the day of the presentation/session.
Duplicate Submissions: Abstract presented prior to the 2020 Heart Rhythm Scientific Sessions with substantially similar materials at any major North American meeting will be disqualified.
Industry Abstract Submissions: Abstract submissions from industry representatives are allowed. Submissions are required to focus on science and research and not on specific products or services. The abstract presentation may NOT be sales presentations and/or endorsement for products or services.
LBCT Abstract Acceptance and Withdrawal
The Presenting Author must submit a request via email to the following address to withdraw an abstract from #HRS2020 (abstracts@HRSonline.org). Please note that the Presenting Author will receive an e-mail confirmation upon completion of the withdrawal. The request must fulfill the following requirements:
- Subject line of the e-mail must include "Abstract Withdrawal"
- Inclusion of abstract title and number
- Reason for the withdrawal
The deadline to withdraw an abstract and avoid publication in the May 2020 issue of HeartRhythm Journal is Friday, April 3, 2020, 11:59 PM EST.
To withdraw a LBCT abstract from #HRS2020 the Presenting Author must submit a request in writing to abstracts@HRSonline.org by April 3, 2020, 11:59 PM EST.
Accepted LBCT abstracts are embargoed until the time of presentations. This means that information regarding any abstract submission may not be released before this time. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation.
If you have questions or comments about abstracts, please contact the Heart Rhythm Society at abstracts@HRSonline.org.